Bio Medica Laboratories IPO
Open SmeCurrent GMP
₹0 (0.00%)
Price Band
₹ 132 – 139
Lot Size
1000
Issue Size
₹52 Cr
Minimum Investment
₹278000 (2000 Shares)
Listing Date
29 May 2026
Subscription
2.31x
About the Company
Bio Medica Laboratories is engaged in the manufacturing of pharmaceutical parenteral formulations, offering a diverse portfolio of ethical drugs, generic medicines, and over-the-counter (OTC) products. The company specializes in the production of liquid and dry powder injectables available in both single-dose and multi-dose formats, catering to the requirements of human as well as veterinary healthcare sectors.
Product Portfolio
- Liquid Injectables: 58 products
- Dry Powder Injectables: 15 products
The company provides a comprehensive range of pharmaceutical products, including:
- Generic drugs
- Branded pharmaceuticals
- OTC medications
- Other injectable formulations
Business Model
Bio Medica Laboratories operates primarily on a Business-to-Business (B2B) contract manufacturing model. The company develops and manufactures formulations for various pharmaceutical companies based on their specific requirements, product specifications, and quality standards.
Certifications & Compliance
The company adheres to stringent quality and regulatory standards and has been awarded:
- Good Manufacturing Practices (GMP) Certification
- Good Laboratory Practices (GLP) Certification
These certifications have been issued by the Food & Drugs Administration, Madhya Pradesh.
Manufacturing Facilities
Bio Medica Laboratories operates two manufacturing facilities located in Indore, equipped to support the production of high-quality injectable pharmaceutical formulations.
Promoters
- Mukesh Mehta
- Pradeep Mehta
Promoters Holding
Holding Pre Issue
99.99%
Holding Post Issue
0.00%
Objects of the Issue
The Company Bio Medica Laboratories IPO proposes to utilise the Net Proceeds from the Issue towards the following objects.
- Repayment of Loan
- Enhancement of its existing production capabilities by setting up of new manufacturing facility at the existing premises
- General Corporate Purposes
Address / Contact Info
Bio Medica Laboratories Ltd.
Plot No. 11B-11C, Sector-E, Sanwer Road
Industrial Area, Industrial Estate (Indore),
Indore, Madhya Pradesh, 452015
Phone: +91 7314102751
Email: companysecretary@biomedica.co.in
Website: http://www.biomedica.co.in/
IPO Snapshot
IPO Timeline (Tentative)
IPO Open Date
Thursday, 21 May 2026
IPO Close Date
Monday, 25 May 2026
Basis of Allotment
Tuesday, 26 May 2026
Initiation of Refunds
Wednesday, 27 May 2026
Credit of Shares to Demat
Wednesday, 27 May 2026
Listing Date
Friday, 29 May 2026 — NSE & BSE
Important Dates
Open Date
21 May 2026
Close Date
25 May 2026
Basis Of Allotment
26 May 2026
Listing Date
29 May 2026
Financial Performance (₹ in Crores)
| Particular | 30 Nov 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 65.17 | 39.12 | 19.53 | 17.57 |
| Revenue | 28.63 | 38.33 | 15.34 | 16.25 |
| Profit After Tax | 8.66 | 9.79 | 2.5 | 0.33 |
| Net Worth | 17.12 | 14.73 | 4.94 | 2.44 |
| Reserve & Surplus | 7.94 | 5.55 | 4.84 | 2.34 |
| Total Borrowings | 38.17 | 15.01 | 10.49 | 9.61 |
EPS Pre
10.67%
EPS Post
10.33%
P/E Pre
13.03
P/E (Post Issue)
13.45x
Company Financial Information
KPI Information (₹ in Crores)
| Particular | Nov 2025 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| ROE % | 54.41 | 99.59 | 67.74 | 13.92 |
| ROCE % | 23.22 | 48.2 | 29.92 | 10.16 |
| Debt / Equity | 2.23 | 1.02 | 2.12 | 3.94 |
| RoNW % | 54.41 | 99.59 | 67.74 | 13.92 |
| PbW | 0 | 0 | 0 | 0 |
| Pat Margin % | 30.35 | 25.64 | 16.39 | 2.06 |
Return Ratio
IPO Reservations
| Category | Shares Offered | Shares Offered % | Max Allotee |
|---|---|---|---|
| Qualified Institutions | 36000 | 1 | 0 |
| Non-Institutional | 1755000 | 48.98 | 0 |
| BNII | 1170000 | 32.65 | 0 |
| SNII | 585000 | 16.33 | 0 |
| Retail Investors | 1792000 | 50.01 | 0 |
| Total | 3583000 | 100 | 0 |
Subscription Status ( Mon, 25 May 26 01:42 PM)
| Category | Shares Offered | Shares Bid For | Subscription (x) |
|---|---|---|---|
| Qualified Institutions | 36000 | 574000 | 15.94x |
| Non-Institutional | 1755000 | 2475000 | 1.41x |
| BNII | 1170000 | 1193000 | 1.02x |
| SNII | 585000 | 1282000 | 2.19x |
| Retail Investors | 1792000 | 5228000 | 2.92x |
| Total | 3583000 | 8277000 | 2.31x |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Peer Comparision
| Company | Face Value | PE Ratio | EPS Basic | EPS Diluted | RoNW | Net Assets |
|---|---|---|---|---|---|---|
| Bio Medica Laboratories Ltd | 10 | 0.00 | 10.67 | 10.67 | 99.59 | 16.05 |
| Zenotech Laboratories Ltd | 10 | 0.00 | 0.92 | 0.92 | 6.01 | 15.76 |
| Shukra Pharmaceuticals Ltd | 1 | 47.57 | 0.22 | 0.22 | 15.90 | 1.43 |
Lot Size & Investment Details
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 2 | 2,000 | 278,000.00 |
| Retail (Max) | 2 | 2,000 | 278,000.00 |
| S-HNI (Min) | 3 | 3,000 | 417,000.00 |
| S-HNI (Max) | 7 | 7,000 | 973,000.00 |
| B-HNI (Min) | 8 | 8,000 | 1,112,000.00 |
Registrar
Skyline Financial Services Private Ltd
02228511022
info@skylinerta.com
https://www.skylinerta.com
Book Running Lead Managers
- Narnolia Financial Services
RHP Document
DRHP Document
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Bio Medica Laboratories IPO is a Book-building IPO worth ₹52 crores. The price band is ₹132 to 139 per share. The IPO opens on Thu, May 21, 2026 and closes on Mon, May 25, 2026. It will be listed on BSE and NSE. Skyline Financial Services Private Ltd is the registrar.
The Bio Medica Laboratories IPO opens on Thu, May 21, 2026 and closes on Mon, May 25, 2026
Bio Medica Laboratories IPO Price Band is ₹132 to 139.
Bio Medica Laboratories IPO lot size is 1000, and the minimum amount required for application is ₹278000.
The minimum investment for Bio Medica Laboratories IPO is approximately ₹278000 based on the upper price band.
To apply for the Bio Medica Laboratories IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of Mon, May 25, 2026. After submission, funds are blocked until the basis of allotment of Bio Medica Laboratories IPO is finalised.
Bio Medica Laboratories IPO issue size is ₹52 crores.
Bio Medica Laboratories IPO allotment date is Sat, Jun 27, 2026.
The registrar for Bio Medica Laboratories IPO is Skyline Financial Services Private Ltd. Investors can go to Skyline Financial Services Private Ltd website for IPO allotment status, refund processing, and other queries related to Bio Medica Laboratories IPO through their official website or helpline.